Medicine and Dentistry
Sarcoidosis
100%
Cohort Analysis
75%
Prevalence
54%
Comorbidity
43%
Health Care Cost
36%
Diagnosis
30%
Corticosteroid Therapy
25%
Pyoderma gangrenosum
25%
Pneumococcus Polysaccharide
25%
Wart Virus Vaccine
25%
Meta-Analysis
25%
Malignant Neoplasm
25%
Progression Free Survival
25%
Systemic Scleroderma
25%
High Risk Population
25%
Cohort Effect
25%
Carcinoma
25%
Interstitial Lung Disease
25%
Recurrent Disease
25%
Chemoradiotherapy
25%
Pneumococcal Infection
25%
Chronic Obstructive Pulmonary Disease
25%
Corticosteroid
9%
Disease Severity
7%
Patient Registry
7%
Population
7%
Hazard Ratio
7%
Disease
6%
Systemic Disease
6%
Drug Therapy
5%
Biochemistry, Genetics and Molecular Biology
Comorbidity
100%
Cohort Study
77%
Population
58%
Patient Registry
58%
Prevalence
36%
Progeny
25%
Work Capacity
25%
Smoking
25%
High Risk Population
25%
Polysaccharide
25%
Awareness
25%
Corticosteroid
14%
Embase
9%
Cross Sectional Study
9%
Prospective Study
6%
Medline
6%
Nursing and Health Professions
Sarcoidosis
75%
Comorbidity
62%
Prevalence
50%
Obstructive Lung Disease
50%
Health Hazard
25%
Population
25%
Lung Cancer
25%
Lung Tuberculosis
25%
Patient with Depression
25%
Diagnosis
25%
Pittsburgh Sleep Quality Index
12%
Common Cold
12%
Sample Size
12%
Fatigue
12%
Outpatient Department
12%
Corticosteroid
9%
Disease
7%
Drug Therapy
7%
Lung Function Test
5%
Nicotine Withdrawal
5%
